| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.33 | 0.02 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |